Normal hematopoietic progenitor subsets have distinct reactive oxygen species, BCL2 and cell-cycle profiles that are decoupled from maturation in acute myeloid leukemia

Normal hematopoietic progenitor subsets have distinct reactive oxygen species, BCL2 and cell-cycle profiles that are decoupled from maturation in acute myeloid leukemia

In acute myeloid leukemia (AML) quiescence and low oxidative state, linked to BCL2 mitochondrial regulation, endow leukemic stem cells (LSC) with treatment-resistance. LSC in CD34+ and more mature CD34- AML have heterogeneous immunophenotypes overlapping with normal stem/progenitor cells (SPC) but m...

Full description

Bibliographic Details
Main Authors:	Khan, N, Hills, R, Knapper, S, Steadman, L, Qureshi, U, Rector, J, Bradbury, C, Russell, N, Vyas, P, Burnett, A, Grimwade, D, Hole, P, Freeman, S
Other Authors:	Bertolini, F
Format:	Journal article
Language:	English
Published:	Public Library of Science 2016

Similar Items

Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia.
by: Vyas, P, et al.
Published: (2015)

Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia
by: Craddock, C, et al.
Published: (2013)

Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia.
by: Craddock, C, et al.
Published: (2013)

Assessment of minimal residual disease in acute myeloid leukemia.
by: Grimwade, D, et al.
Published: (2010)

Residual Disease Detection by Flow Cytometry Predicts Risk of Relapse and Overall Survival in Patients with Acute Myeloid Leukemia Following Reduced Intensity- and Myeloablative-Allogeneic Hematopoietic Cell Transplantation
by: Bradbury, C, et al.
Published: (2012)

Residual Disease Detection by Flow Cytometry Predicts Risk of Relapse and Overall Survival in Patients with Acute Myeloid Leukemia Following Reduced Intensity- and Myeloablative- Allogeneic Hematopoietic Cell Transplantation
by: Bradbury, C, et al.
Published: (2012)

Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia.
by: Jan, M, et al.
Published: (2012)

BCL-2 inhibitor and conventional chemotherapy combinations for acute myeloid leukemia: shifting from the unfit to the fit patient with AML
by: Ossenkoppele, G, et al.
Published: (2020)

Stem cell biology is population biology: differentiation of hematopoietic multipotent progenitors to common lymphoid and myeloid progenitors.
by: Mangel, M, et al.
Published: (2013)

Myeloid pre-leukemia and leukemia of Down syndrome
by: Cruz Hernandez, D, et al.
Published: (2020)

Higher daunorubicin exposure benefits FLT3 mutated acute myeloid leukemia
by: Burnett, A, et al.
Published: (2016)

Prognostic value of monitoring a candidate immunophenotypic leukaemic stem/progenitor cell population in patients allografted for acute myeloid leukaemia.
by: Bradbury, C, et al.
Published: (2014)

ESTABLISHMENT OF LYMPHO-MYELOID RESTRICTED PROGENITORS PRIOR TO THE EMERGENCE OF DEFINITIVE HEMATOPOIETIC STEM CELLS
by: Boiers, C, et al.
Published: (2013)

Heterogeneous leukemia stem cells in myeloid blast phase chronic myeloid leukemia
by: Kinstrie, R, et al.
Published: (2016)

An overview of targeted therapies in acute myeloid leukemia
by: Turkalj, S, et al.
Published: (2023)

Combined inhibition of XIAP and BCL2 drives maximal therapeutic efficacy in genetically diverse aggressive acute myeloid leukemia
by: Hashimoto, M, et al.
Published: (2021)

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
by: Reinhardt, K, et al.
Published: (2010)

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
by: Reinhardt, K, et al.
Published: (2010)

Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment.
by: Mussai, F, et al.
Published: (2013)

Co-Existence of LMPP-Like and GMP-Like Leukemia Stem Cells In Acute Myeloid Leukemia
by: Goardon, N, et al.
Published: (2010)

Co Existence of LMPP Like and GMP Like Leukemia Stem Cells In Acute Myeloid Leukemia
by: Goardon, N, et al.
Published: (2010)

Co Existence of LMPP Like and GMP Like Leukemia Stem Cells In Acute Myeloid Leukemia
by: Goardon, N, et al.
Published: (2010)

High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia
by: Marquis, M, et al.
Published: (2018)

Ezh2 and Runx1 mutations collaborate to initiate lympho-myeloid leukemia in early thymic progenitors
by: Booth, CAG, et al.
Published: (2018)

Hematopoietic stem cell expansion precedes the generation of committed myeloid leukemia-initiating cells in C/EBPalpha mutant AML.
by: Bereshchenko, O, et al.
Published: (2009)

Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia.
by: Goardon, N, et al.
Published: (2011)

Cryopreservation of hematopoietic stem/progenitor cells for therapeutic use.
by: Watt, S, et al.
Published: (2007)

Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro
by: Reyes, Miguel, et al.
Published: (2021)

Mechanisms of progression of myeloid preleukemia to transformed myeloid leukemia in children with Down syndrome
by: Labuhn, M, et al.
Published: (2019)

Autophagy in hematopoiesis and acute myeloid leukemia
by: Watson, A
Published: (2014)

Clinical relevance of failed and missing cytogenetic analysis in acute myeloid leukaemia
by: Chilton, L, et al.
Published: (2017)

New directions for emerging therapies in acute myeloid leukemia: the next chapter
by: Daver, N, et al.
Published: (2020)

Transcriptome Analysis Identifies Regulators of Hematopoietic Stem and Progenitor Cells
by: Gazit, Roi, et al.
Published: (2014)

Conflicting data on the prognostic significance of FLT3/TKD mutations in acute myeloid leukemia might be related to the incidence of biallelic disease.
by: Mead, A, et al.
Published: (2008)

Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21
by: Roy, A, et al.
Published: (2012)

Lack of autophagy in the hematopoietic system leads to loss of hematopoietic stem cell function and dysregulated myeloid proliferation.
by: Mortensen, M, et al.
Published: (2011)

Can cytoplasmic nucleophosmin be detected by immunocytochemical staining of cell smears in acute myeloid leukemia?
by: Mattsson, G, et al.
Published: (2010)

Expression of CD33 is a predictive factor for effect of gemtuzumab ozogamicin at different doses in adult acute myeloid leukaemia
by: Khan, N, et al.
Published: (2016)

Targeting MTHFD2 in acute myeloid leukemia
by: Pikman, Yana, et al.
Published: (2017)

Impact of alginate encapsulation on myeloid leukemia cells.
by: Kyaw Htay.
Published: (2013)